Jinsmaa Y, Yoshikawa M (1999). “Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein”. Peptides20 (8): 957-962. doi:10.1016/S0196-9781(99)00088-1. PMID10503774.
Püschel G, Mentlein R, Heymann E (1982). “Isolation and characterization of dipeptidyl peptidase IV from human placenta”. Eur. J. Biochem.126 (2): 359–365. doi:10.1111/j.1432-1033.1982.tb06788.x. PMID6751824.
Kurek M, Przybilla B, Hermann K, Ring J (1992). “A naturally occurring opioid peptide from cow's milk, β-casomorphine-7, is a direct histamine releaser in man”. Int. Arch. Allergy Immunol.97 (2): 115–120. doi:10.1159/000063326. PMID1374738.
Christison GW, Ivany K (2006). “Elimination diets in autism spectrum disorders: any wheat amidst the chaff?”. J. Dev. Behav. Pediatr.27 (2 Suppl 2): S162–71. doi:10.1097/00004703-200604002-00015. PMID16685183.
Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BD (August 2007). “Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory”. Anal. Bioanal. Chem .388 (8): 1643–51. doi:10.1007/s00216-007-1301-4. PMID17520243.
Cass H, Gringras P, March J, et al. (September 2008). “Absence of urinary opioid peptides in children with autism”. Arch. Dis. Child.93 (9): 745–50. doi:10.1136/adc.2006.114389. PMID18337276.
Hunter LC, O'Hare A, Herron WJ, Fisher LA, Jones GE (February 2003). “Opioid peptides and dipeptidyl peptidase in autism”. Dev. Med. Child Neurol.45 (2): 121–8. doi:10.1111/j.1469-8749.2003.tb00915.x. PMID12578238.
Zhongjie Sun, J. Robert Cade (1999). “A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats”. Autism3 (1): 85-95. doi:10.1177/1362361399003001007.
nih.gov
pubmed.ncbi.nlm.nih.gov
Jinsmaa Y, Yoshikawa M (1999). “Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein”. Peptides20 (8): 957-962. doi:10.1016/S0196-9781(99)00088-1. PMID10503774.
Püschel G, Mentlein R, Heymann E (1982). “Isolation and characterization of dipeptidyl peptidase IV from human placenta”. Eur. J. Biochem.126 (2): 359–365. doi:10.1111/j.1432-1033.1982.tb06788.x. PMID6751824.
Stanislaw Kaminski, Anna Cielinska, Elzbieta Kostyra (2007). “Polymorphism of bovine beta-casein and its potential effect on health”. Journal of Applied Genetics48 (3): 189–198. PMID17666771.
Kurek M, Przybilla B, Hermann K, Ring J (1992). “A naturally occurring opioid peptide from cow's milk, β-casomorphine-7, is a direct histamine releaser in man”. Int. Arch. Allergy Immunol.97 (2): 115–120. doi:10.1159/000063326. PMID1374738.
Christison GW, Ivany K (2006). “Elimination diets in autism spectrum disorders: any wheat amidst the chaff?”. J. Dev. Behav. Pediatr.27 (2 Suppl 2): S162–71. doi:10.1097/00004703-200604002-00015. PMID16685183.
Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BD (August 2007). “Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory”. Anal. Bioanal. Chem .388 (8): 1643–51. doi:10.1007/s00216-007-1301-4. PMID17520243.
Cass H, Gringras P, March J, et al. (September 2008). “Absence of urinary opioid peptides in children with autism”. Arch. Dis. Child.93 (9): 745–50. doi:10.1136/adc.2006.114389. PMID18337276.
Hunter LC, O'Hare A, Herron WJ, Fisher LA, Jones GE (February 2003). “Opioid peptides and dipeptidyl peptidase in autism”. Dev. Med. Child Neurol.45 (2): 121–8. doi:10.1111/j.1469-8749.2003.tb00915.x. PMID12578238.